Literature DB >> 19515005

The encapsulation and release of guanosine from PEGylated liposomes.

Yan Er1, Timothy J Barnes, Daniel Fornasiero, Clive A Prestidge.   

Abstract

The encapsulation and release kinetics of guanosine from liposomes and polyethylene glycol (PEG)-modified liposomes are reported. Specifically, the influence of PEG chain length, PEGylation level, lipid type, drug-loading level, temperature, and solution conditions (i.e., salt and pH effects) on the rate and mechanism for release have been determined. Increasing PEGylation significantly reduced the guanosine release kinetics; this is more significant for greater molecular weight PEG and is correlated with the PEG layer thickness. Further, the mechanism for guanosine release changed from diffusion to interfacial control as the PEG level increased. The interfacial structure introduced by PEG also increased the activation energy required for guanosine transport across the lipid bilayer from 14 to 22 kJ mol(-1). Findings from this study provide further insight into optimizing the formulation of Stealth liposomes.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19515005     DOI: 10.1080/08982100802673940

Source DB:  PubMed          Journal:  J Liposome Res        ISSN: 0898-2104            Impact factor:   3.648


  6 in total

1.  Development of stealth liposomal formulation of celecoxib: In vitro and in vivo evaluation.

Authors:  M Yasmin Begum; Riyaz Ali M Osmani; Ali Alqahtani; Mohammed Ghazwani; Umme Hani; Hissana Ather; Akhtar Atiya; Mohamed Rahamathulla; Ayesha Siddiqua
Journal:  PLoS One       Date:  2022-04-26       Impact factor: 3.752

2.  PEGylated Lipova E120 liposomes loaded with celecoxib: in-vitro characterization and enhanced in-vivo anti-inflammatory effects in rat models.

Authors:  Vivek Dave; Ashish Gupta; Priyanka Singh; Kajal Tak; Swapnil Sharma
Journal:  J Biosci       Date:  2019-09       Impact factor: 1.826

Review 3.  Nucleic acid aptamer-guided cancer therapeutics and diagnostics: the next generation of cancer medicine.

Authors:  Dongxi Xiang; Sarah Shigdar; Greg Qiao; Tao Wang; Abbas Z Kouzani; Shu-Feng Zhou; Lingxue Kong; Yong Li; Chunwen Pu; Wei Duan
Journal:  Theranostics       Date:  2015-01-01       Impact factor: 11.556

4.  Development of a novel cell-based assay system EPISSAY for screening epigenetic drugs and liposome formulated decitabine.

Authors:  Sue Ping Lim; Raman Kumar; Yamini Akkamsetty; Wen Wang; Kristen Ho; Paul M Neilsen; Diego J Walther; Rachel J Suetani; Clive Prestidge; David F Callen
Journal:  BMC Cancer       Date:  2013-03-13       Impact factor: 4.430

5.  Surface engineering of liposomes for stealth behavior.

Authors:  Okhil K Nag; Vibhudutta Awasthi
Journal:  Pharmaceutics       Date:  2013-10-25       Impact factor: 6.321

6.  Synthesis of Two Methotrexate Prodrugs for Optimizing Drug Loading into Liposomes.

Authors:  Valentina Di Francesco; Martina Di Francesco; Paolo Decuzzi; Roberto Palomba; Miguel Ferreira
Journal:  Pharmaceutics       Date:  2021-03-04       Impact factor: 6.525

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.